Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2023-11-21 2023-11-20
Drug Identification Number 02521539 02521539
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM PIPERACILLIN AND TAZOBACTAM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TAZOBACTAM PIPERACILLIN TAZOBACTAM PIPERACILLIN
Strength(s) 4.5G 36G 4.5G 36G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1PSOIJ 1PSOIJ
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-10-23 2023-10-23
Estimated end date 2023-11-17 2023-11-17
Actual end date 2023-11-20 2023-11-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments